Stay updated on Eteplirsen Safety in Early Duchenne Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.

Latest updates to the Eteplirsen Safety in Early Duchenne Clinical Trial page
- Check4 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, indicating a backend/software update with no substantive content changes.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, indicating a minor version update to the page or its documentation. The change does not reveal any user-facing content changes.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a small platform update that does not alter study details.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page's revision label was updated to v3.6.3, representing a minor update to the page's documentation/versioning metadata.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a minor update to the documentation or interface. It does not reflect changes to the study information or results.SummaryDifference0.1%

- Check82 days agoChange DetectedNew help/navigation sections have been added to the study record page, including How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment header formatting was updated and the revision label changed from v3.5.5 to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Eteplirsen Safety in Early Duchenne Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.